05 Oct 2018

FUJIFILM SONOSOFT SOLIDIFIES WORKFLOW WITH SYNCHRONICITY

  FUJIFILM SonoSite Inc., developers of point-of-care ultrasound solutions, has entered the medical informatics space with the launch of SonoSite Synchronicity, designed to optimize workflows by integrating with existing data management systems and enabling the use of current user login credentials. The software can be implemented across multiple departments in an organization to standardize operations. In

0
27 Sep 2018

MEDTRONIC IN $1.6 BILLION DEAL FOR MAZOR ROBOTICS

          Medtronic has picked up the rest of Israel-based Mazor Robotics in a $1.64 billion deal that is to close in Medtronic’s third quarter ending Jan. 25, 2019. The merger was unveiled at the North American Spine Society 2018 Annual Meeting in Los Angeles Sept. 26. The definitive merger deal

0
06 Sep 2018

PENUMBRA ACQUIRES 90% OF MVI HEALTH JV, LAUNCHES THROMBECTOMY DEVICES

  Penumbra has acquired 40 percent of the outstanding shares of virtual reality joint venture MVI Health from collaborator Sixense, boosting its interest to 90 percent, and said it launched the Penumbra Jet 7 and Jet D reperfusion catheters. The joint venture intends to commercialize healthcare applications of virtual reality technology,

0
21 Aug 2018

ACUSON SEQUOIA ULTRASOUND COMING TO A CITY NEAR YOU

Siemens Medical Solutions USA Inc. is taking its ACUSON Sequoia Ultrasound System on the road with nine stops between Aug. 23 and Oct. 4.   Stops include: August 23: Philadelphia, The Union League August 23: Atlanta, The Westin Buckhead Atlanta August 28: Cincinnati, Hyatt Regency Cincinnati August 30: Detroit, The

0
10 Aug 2018

GLOBAL ULTRASOUND DEVICES MARKET ANALYZED THROUGH 2023

           A global ultrasound devices market report has added to the Research and Markets  offering. According to the “Global Ultrasound Devices Market — Segmented by Application, Technology, Type, and Geography – Growth, Trends, and Forecast (2018-2023)” report, the market is expected to register a CAGR of about 4 percent during 2018-2023. The

0
07 Aug 2018

MICROSOFT IS DEVELOPING A GLASSES-BASED BLOOD PRESSURE MONITOR

            Microsoft is developing new blood pressure monitoring technology called Glabella, which comes equipped on a pair of glasses that passively collects physiological data on the wearer, according to a research paper recently released by the company. The paper was written by Christian Holz, Microsoft Research in Redmond; and  Edward J.

0
01 Aug 2018

GE HEALTHCARE, LANTHEUS BEGIN A PHASE 3 CLINICAL TRIAL OF FLURPIRIDAZ TO TREAT CAD

GE Healthcare and Lantheus Holdings Inc., parent company of Lantheus Medical Imaging Inc., have started a second Phase 3 clinical trial of Flurpiridaz 18F (called the AURORA study), an investigational agent being evaluated for the detection of coronary artery disease (CAD), the most common form of heart disease.1 CAD affects an estimated

0
28 Jul 2018

POLIDOCANOL INJECTABLE FOAM: WHEN VEINS DON’T TAKE A STRAIGHT PATH

Patient presents with bilateral bulging varicosities   By Ajit Naidu, MD An estimated one-third of the population in Western countries has untreated venous disease.[i] Some of these individuals have lived with debilitating symptoms of venous insufficiency for a decade or more because their primary care physicians or OB/GYNs have told

0
25 Jul 2018

ECHONOUS VEIN DESIGNED TO IMPROVE FIRST-TIME STICKS

EchoNous, a Seattle provider focused on delivering intelligent medical tools, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the EchoNous Vein, an ultrasound-based tool designed specifically for nurses to improve peripheral IV (PIV) catheter placements. Developed for usage across a wide range of patients including both adults

0
16 Jul 2018

JEFF SOINSKI INTERVIEW WITH MEDGADGET: AVINGER MAKES P.A.D. TREATMENT SAFER WITH REAL-TIME INTRAVASCULAR IMAGING

  By Michael Batista Peripheral artery disease (P.A.D.), a circulatory condition in which narrowed arteries reduce blood flow to the extremities, is projected to affect more than 21 million patients in the United States by 2020. Common treatments include balloon angioplasty, atherectomy, stenting and bypass, all of which require physicians

0